Elucidata Corporation Revenue and Competitors

Boston, MA USA

Location

$7.6M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Elucidata Corporation's estimated annual revenue is currently $56M per year.(i)
  • Elucidata Corporation received $1.7M in venture funding in June 2018.
  • Elucidata Corporation's estimated revenue per employee is $193,750
  • Elucidata Corporation's total funding is $7.6M.

Employee Data

  • Elucidata Corporation has 289 Employees.(i)
  • Elucidata Corporation grew their employee count by -7% last year.

Elucidata Corporation's People

NameTitleEmail/Phone
1
Co-Founder & CEOReveal Email/Phone
2
Scientific Co-FounderReveal Email/Phone
3
Co-Founder & CTOReveal Email/Phone
4
Data ScientistReveal Email/Phone
5
Director EngineeringReveal Email/Phone
6
Director Product DesignReveal Email/Phone
7
Director - SolutionsReveal Email/Phone
8
Senior Product ManagerReveal Email/Phone
9
Manager Strategic InitiativesReveal Email/Phone
10
Engineering ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Elucidata Corporation?

Elucidata's mission is to use data analytics to transform decision-making processes in R&D labs in biotechnology and pharmaceutical companies. We build algorithms and softwares to process, analyze and visualize large -omics data across metabolomics, genomics, transcriptomics, and proteomics among others. We build our own products, provide customized solutions for our partners, and analyze datasets to answer specific questions.

keywords:Pharmaceuticals, Bioinformatics, Technology, Science

$7.6M

Total Funding

289

Number of Employees

$56M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Elucidata Corporation News

2021-02-04 - Elucidata Raises $5M in Pre-Series A Funding

Elucidata, a Cambridge, Mass.-based biomedical molecular data company, closed a $5m pre-Series A funding. The round was led by IvyCap Ventures with participation from Hyperplane Venture Capital and several angel investors. The company intends to use the funds to accelerate product development, ...

2021-01-28 - Drug Discovery Startup Elucidata Raises $5 Mn To Fuel Post-Covid Demand

Delhi-based biomedical molecular data company Elucidata has raised $5 Mn in a pre-Series A funding round led by IvyCap Ventures. The round also saw participation from Hyperplane Venture Capital and a few angel investors. The company says that the funds will be utilised to accelerate product dev ...

2021-01-28 - [Funding alert] Biomedical molecular data startup Elucidata raises $5M in pre-Series A round led by IvyCap Ventures

Biomedical molecular data firm Elucidata on Thursday said it has raised $5 million (around Rs 36 crore) in a funding round led by IvyCap Ventures. The pre-Series A funding round also saw participation from Hyperplane Venture Capital and a few angel investors, Elucidata said in a statement. The ...

2018-12-19 - Auron and Elucidata Announce Scientific Collaboration to ...

BOSTON & WELLESLEY, Mass.--(BUSINESS WIRE)--Auron Therapeutics and Elucidata Corporation today announced a scientific ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$69.9M28913%N/A
#2
$83.9M289-1%$3M
#3
$45M290-16%N/A
#4
$65.9M29247%$240.8M
#5
$41.8M2929%N/A

Elucidata Corporation Funding

DateAmountRoundLead InvestorsReference
2018-06-19$1.7MUndisclosedHyperplane Venture CapitalArticle